| |
| |
|
| Insider
Information: |
Mclaughlin Kevin F |
| Relationship: |
Director |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
11,900 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$573,342 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
11,900 |
|
|
| Total
Value |
$573,342 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
SVP, CFO and Treasurer |
2021-11-19 |
0 |
2014-05-19 |
0 |
Premium* |
|
|
Vericel Corp |
VCEL |
|
2024-05-01 |
11,900 |
2020-04-29 |
0 |
Premium* |
|
|
Decibel Therapeutics, Inc. |
DBTX |
Director |
2023-09-25 |
0 |
2023-06-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
101 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2017-01-04 |
4 |
AS |
$26.87 |
$46,667 |
D/D |
(1,700) |
70,900 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2018-08-30 |
4 |
OE |
$27.97 |
$349,625 |
D/D |
12,500 |
56,439 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-09 |
4 |
OE |
$27.97 |
$141,537 |
D/D |
3,872 |
15,088 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-10 |
4 |
OE |
$27.97 |
$16,792 |
D/D |
500 |
11,716 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-14 |
4 |
OE |
$27.97 |
$1,373,159 |
D/D |
42,528 |
53,744 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-08-10 |
4 |
AS |
$28.51 |
$185,432 |
D/D |
(6,500) |
40,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-09-08 |
4 |
AS |
$29.11 |
$196,023 |
D/D |
(6,500) |
40,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2014-10-07 |
4 |
AS |
$29.25 |
$292,500 |
D/D |
(10,000) |
0 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-07-07 |
4 |
AS |
$29.65 |
$207,911 |
D/D |
(7,000) |
35,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2014-08-14 |
4 |
AS |
$29.76 |
$297,810 |
D/D |
(10,000) |
0 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-09-23 |
4 |
OE |
$30.17 |
$778,624 |
D/D |
19,630 |
30,311 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2014-06-09 |
4 |
AS |
$31.16 |
$316,471 |
D/D |
(10,000) |
0 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2014-07-07 |
4 |
AS |
$31.40 |
$317,174 |
D/D |
(10,000) |
0 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2014-05-19 |
4 |
AS |
$31.48 |
$315,143 |
D/D |
(10,000) |
0 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2017-07-05 |
4 |
AS |
$32.00 |
$1,100,800 |
D/D |
(34,400) |
65,300 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-06-08 |
4 |
AS |
$32.37 |
$211,171 |
D/D |
(6,500) |
30,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2014-11-12 |
4 |
AS |
$32.39 |
$331,422 |
D/D |
(10,000) |
10,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2016-05-23 |
4 |
AS |
$34.00 |
$860,200 |
D/D |
(25,300) |
67,600 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2016-07-01 |
4 |
AS |
$34.66 |
$876,898 |
D/D |
(25,300) |
57,600 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-04-07 |
4 |
AS |
$34.80 |
$244,165 |
D/D |
(7,000) |
25,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-02-09 |
4 |
AS |
$36.60 |
$238,179 |
D/D |
(6,500) |
25,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2018-04-03 |
4 |
AS |
$38.31 |
$153,792 |
D/D |
(4,000) |
43,939 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2017-09-12 |
4 |
AS |
$38.32 |
$614,546 |
D/D |
(16,000) |
49,300 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2014-12-08 |
4 |
AS |
$38.52 |
$440,237 |
D/D |
(10,000) |
10,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-01-07 |
4 |
AS |
$38.67 |
$197,306 |
D/D |
(5,000) |
25,000 |
0 |
- |
|
101 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
